IP Library Granted Patent US 7,807,180
Granted Patent B2
US 7,807,180 · App. 11/842,761 · Granted Oct 5, 2010

Poxvirus methods and compositions

Assignee: University of Massachusetts
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,807,180
App. No.
11/842,761
Granted
Oct 5, 2010
Kind
B2
Abstract

Methods and compositions for inducing immune responses against poxviruses are disclosed. The compositions include nucleic acids that encode modified vaccinia and variola antigens. Compositions that include recombinant vaccinia and variola polypeptides are also disclosed.

Claims (9)

1. A method of inducing an immune response to a poxvirus in a mammal, the method comprising administering to a mammal a composition comprising at least one nucleic acid molecule comprising, a nucleotide sequence encoding a variola F8 polypeptide, wherein the nucleotide sequence is codon optimized for expression in both a mammalian cell and a bacterial cell, and has a nucleotide sequence at least 99% identical to SEQ ID NO:15, and wherein the composition is administered in an amount effective to produce an immune response in the mammal against a subsequent poxvirus infection.

2. The method of claim 1 , wherein the composition further comprises a nucleotide sequence encoding one or more of variola A30 and B7 polypeptides.

3. The method of claim 1 , wherein the composition comprises nucleotide sequences encoding all three of variola F8, A30, and B7 polypeptides.

4. The method of claim 2 , wherein the nucleotide sequence encoding one or more of variola A30 and B7 polypeptides is codon optimized for expression in both a mammalian cell and a bacterial cell.

5. The method of claim 4 , wherein the nucleotide sequence encoding the variola A30 polypeptide comprises the nucleotide sequence of SEQ ID NO:17.

6. The method of claim 4 , wherein the nucleotide sequence encoding the variola B7 polypeptide comprises the nucleotide sequence of SEQ ID NO:19.

7. The method of claim 3 , wherein the nucleotide sequences encoding the variola A30 and B7 polypeptides are codon optimized for expression in both a mammalian cell and a bacterial cell.

8. The method of claim 7 , wherein the nucleotide sequence encoding the variola A30 polypeptide comprises the nucleotide sequence of SEQ ID NO:17.

9. The method of claim 7 , wherein the nucleotide sequence encoding the variola B7 polypeptide comprises the nucleotide sequence of SEQ ID NO:19.

Assignments (3)
CONFIRMATORY LICENSE Recorded Dec 21, 2010
From: UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 025528/0831 →
CONFIRMATORY LICENSE Recorded Sep 18, 2008
From: UNIVERSITY OF MASSACHUSETTS MEDICAL SC
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021549/0990 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 22, 2007
From: LU, SHAN; SAKHATSKYY, PAVLO; WANG, DVM, PH.D., SHIXIA
To: UNIVERSITY OF MASSACHUSETTS
Reel/Frame 019994/0948 →
Continuity (1)
Related Publication 20090053256A1 · Feb 26, 2009